Dx dialogues: future directions in the treatment and management of opioid use disorder
Lipi Roy, MD, MPH, FASAM on the future of OUD treatment
Up Next
Dx dialogues: recent advancements and implementation strategies in opioid use disorder treatment
Dx dialogues: artificial intelligence in OUD treatment and outcomes prediction
Dx dialogues: pharmacologic advances for the treatment and management of schizophrenia
Drug addiction: a chronic disease of the brain
Dx dialogues: VMAT2 inhibitors and future treatments for tardive dyskinesia
Dx dialogues: stigma surrounding LAI use for schizophrenia and the importance of patient education
Why you should get medical help for opioid detox
Dx dialogues: why early intervention is critical in managing tardive dyskinesia
Long-term effects of opioid use
Dx dialogues: identifying patients who might benefit from an LAI for schizophrenia
